Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Charles River Laboratories International Inc Completes Acquisition Of Majority Ownership Of Vital River


Monday, 7 Jan 2013 05:00pm EST 

Charles River Laboratories International Inc announced that it has completed its acquisition of a 75% ownership of Vital River, the commercial provider of research models and related services in China, and a licensee of Charles River for the last 10 years. As part of the Vital River acquisition, Charles River will be the exclusive global partner for distribution of model creation services offered through Beijing Vital Star Biotechnology. The services of Beijing Vital Star Biotechnology include humanized model creation utilizing inducible pluripotent stem cell (iPS) and other technologies. Charles River acquired the 75% ownership of Vital River for approximately $27 million, subject to certain post-closing working capital adjustments. 

Company Quote

65.61
0.84 +1.30%
10:48am EST